MedTrace Logo

HepZero:Heparin Free Dialysis With Evodial

NCT01318486 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 265

Last updated 2025-03-14

No results posted yet for this study

Summary

The study hypothesis is that with Evodial in patients requiring heparin free dialysis, the heparin free treatment can be performed easily (without saline flushes or blood predilution) and is at least not inferior and maybe superior to the standard care heparin free treatment in terms of clotting.

Conditions

Interventions

OTHER

Heparin free dialysis technique

Saline flushes or predilution

DEVICE

Evodial

Evodial dialyer

Sponsors & Collaborators

  • Statistical Analysis : CIC CHU Brabois Nancy

    collaborator UNKNOWN

  • Gambro Lundia AB

    collaborator INDUSTRY

  • Baxter Healthcare Corporation

    collaborator INDUSTRY

  • Vantive Health LLC

    lead INDUSTRY

Principal Investigators

  • Maurice Laville, Pr · CHU Edouard Herriot Lyon

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-03-31
Primary Completion
2013-02-28
Completion
2013-02-28

Countries

  • Belgium
  • Canada
  • France
  • Netherlands
  • Poland
  • Spain
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01318486 on ClinicalTrials.gov